Acrivon Therapeutics, Inc.·4

Jul 19, 4:20 PM ET

Miller Mary 4

4 · Acrivon Therapeutics, Inc. · Filed Jul 19, 2024

Insider Transaction Report

Form 4
Period: 2024-07-17
Miller Mary
Chief Legal Officer
Transactions
  • Tax Payment

    Common Stock

    2024-07-17$7.69/sh558$4,29139,151 total
Footnotes (1)
  • [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4